Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Chemotherapy as one of the basic modalities of oncology treatment often leaves permanent
implications and among the most common is infertility as a result of irreversible gonadal
damage. This project sets the primary target to verify the protective effect GnRH analogues
administration to protect ovarian tissue during three different regimens of chemotherapy in
patients with Hodgkin disease (HD) in reproductive age.